New study aims to stop Post-Birth bleeding with smarter drug dosing
NCT ID NCT05370820
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how to best use the drug tranexamic acid (TXA) to prevent postpartum hemorrhage (severe bleeding after childbirth). Researchers will test different doses and ways of giving the drug (by IV or injection) in about 120 women having a C-section or vaginal delivery. The goal is to find the safest and most effective dose to prevent dangerous bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST PARTUM HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
George Washington University Hospital
RECRUITINGWashington D.C., District of Columbia, 20037, United States
-
Inova Fairfax Medical Campus
RECRUITINGFalls Church, Virginia, 22042, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple kit cut newborn deaths by 25%? a major trial in pakistan aims to find out
- Could a pill under the tongue prevent dangerous bleeding after birth?
- Could a new drug beat the standard for preventing postpartum hemorrhage?
- Could a simple drug cocktail stop postpartum bleeding?
- Finger-Stick and phone app could replace needles for anemia in pregnancy
- New uterine drain shows promise in reducing Post-C-Section bleeding